Ascendis Pharma A/S vs Suncor Energy Inc. — how do they compare? Ascendis Pharma A/S trades at $253.76 (market cap $16.67B), while Suncor Energy Inc. trades at $63.4 (market cap $74.07B). The key difference: Suncor Energy Inc. is far larger — about 4.4× Ascendis Pharma A/S's market cap, and Suncor Energy Inc. pays a 2.7% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.
| ASND | SU | |
|---|---|---|
Market Cap | $16.67B | $74.07B |
Sector | Health | Energy |
52-Week High | $277.18 | $69.73 |
52-Week Low | $189.74 | $38.17 |
Enterprise Value | $17.04B | $80.75B |
Dividend Yield | — | 2.7% |
Trailing returns across standard periods
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Read more on ASND →Suncor Energy Inc is an integrated energy company. The company's operations include oil sands development, production and upgrading, offshore oil and gas, petroleum refining in Canada and the U.S. and the company's PetroCanada retail and wholesale distribution networks. The company is developing petroleum resources while advancing the transition to a low-emissions future through investment in power, renewable fuels and hydrogen. It also conducts energy trading activities focused principally on the marketing and trading of crude oil, natural gas, byproducts, refined products and power.
Read more on SU →